The main features of our IVD reagents are: Versatility, validation, conjugation, reproducibility, broad portfolio, specifity and sensitivity, technical support, costs reduction and fast delivery. If you want to know more, just click on each of the features.
Our IVD reagents are provided for research and commercial use in vitro: not for human in vivo or therapeutic use.
Our IVD reagents are in liquid or lyophilized (dry powder) format. Their shipment will be made with dry ice in case of being in liquid format, or at room temperature in case of being in lyophilized format.
If the reagent is in liquid format, upon arrival, it should be aliquoted in order to avoid repeated freezing and thawing cycles and stored at -20oC to -80oC. Reagents should be maintained frozen at high concentrations. If the reagent is in lyophilized format, upon arrival, it should be stored at 4oC to -20oC in vertical position, avoiding all possible humidity and maintaining the vials dry. Once reconstituted, it should be stored as previously indicated.
In order to defrost the product, maintain the aliquot at 25oC without shaking to avoid aggregation.
Before making test dilutions and after the protein has been defrosted, it is recommended to remove possible protein aggregates by centrifuging the stock solution, avoiding alterations in the immobilisation of the biomolecule to the solid surface.
During shipment, small volumes of product will occasionally become entrapped in the seal of the product vial. For products with volumes of 200 µl or less, we recommend tapping the vial on a hard surface or briefly centrifuging the vial in a tabletop centrifuge to dislodge any liquid in the containers cap. Although proteins are expressed in non-pathogenic E. coli and P. pastoris and bacterial integrity is destroyed during purification, the protein preparation should be handled as potentially infectious.
The reagent will remain stable for a minimum of four years if the indicated storage conditions are met. After that, a retest will be required.